Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
RZLTthis companyRezolute, Inc.	$4.11	-6.93×	5.37×	0×	-6.4×	-98.6%	0.0%	0.0%	0.0%	-77.1%	-81.3%	-12.0%	0.01×	0.12×	0×	9.44×	0.0%	1	11.27	2	C
RAREUltragenyx Pharmaceutical Inc.	$15.98	-3.95×	-28.35×	3.37×	-6.56×	-2636.3%	83.8%	-79.5%	-85.4%	718.8%	-43.5%	-20.8%	-15.95×	-1.78×	-8.63×	2.48×	0.0%	2	-5.22	2	B-
RLYBRallybio Corporation	$15.64	-3.45×	0.53×	36.02×	0.01×	-35.3%	89.3%	-3270.9%	-1046.4%	-15.5%	-48.3%	-96.5%	0×	1.12×	0×	14.5×	0.0%	6	13.79	4	A
ZVRAZevra Therapeutics, Inc.	$11.81	6.4×	3.2×	4.65×	5.03×	-449.8%	84.5%	-4.0%	78.2%	53.8%	-1.7%	-0.5%	0.41×	0.01×	-0.53×	5.68×	0.0%	6	4.53	4	A-
Peer median	—	-3.45×	0.53×	4.65×	0.01×	-449.8%	84.5%	-79.5%	-85.4%	53.8%	-43.5%	-20.8%	0×	0.01×	-0.53×	5.68×	0.0%	6	4.53	4	—